-
1
-
-
79956328903
-
Molecular mechanisms and clinical applications of angiogenesis
-
Carmeliet P and Jain RK (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307.
-
(2011)
Nature
, vol.473
, pp. 298-307
-
-
Carmeliet, P.1
Jain, R.K.2
-
2
-
-
76749083490
-
Lymphangiogenesis: Molecular mechanisms and future promise
-
Tammela T and Alitalo K (2010). Lymphangiogenesis: molecular mechanisms and future promise. Cell 140, 460-476.
-
(2010)
Cell
, vol.140
, pp. 460-476
-
-
Tammela, T.1
Alitalo, K.2
-
3
-
-
66949151064
-
Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis
-
Doeden K, Ma Z, Narasimhan B, Swetter SM, Detmar M, and Dadras SS (2009). Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. J Cutan Pathol 36, 772-780.
-
(2009)
J Cutan Pathol
, vol.36
, pp. 772-780
-
-
Doeden, K.1
Ma, Z.2
Narasimhan, B.3
Swetter, S.M.4
Detmar, M.5
Dadras, S.S.6
-
4
-
-
31144452218
-
Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma
-
Lee AH, Pinder SE, Macmillan RD, Mitchell M, Ellis IO, Elston CW, and Blamey RW (2006). Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 42, 357-362.
-
(2006)
Eur J Cancer
, vol.42
, pp. 357-362
-
-
Lee, A.H.1
Pinder, S.E.2
Macmillan, R.D.3
Mitchell, M.4
Ellis, I.O.5
Elston, C.W.6
Blamey, R.W.7
-
5
-
-
0036067286
-
Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer
-
Hyung WJ, Lee JH, Choi SH, Min JS, and Noh SH (2002). Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol 9, 562-567.
-
(2002)
Ann Surg Oncol
, vol.9
, pp. 562-567
-
-
Hyung, W.J.1
Lee, J.H.2
Choi, S.H.3
Min, J.S.4
Noh, S.H.5
-
6
-
-
77955512358
-
Lymphangiogenesis and lymphatic metastasis in breast cancer
-
Ran S, Volk L, Hall K, and Flister MJ (2010). Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology 17, 229-251.
-
(2010)
Pathophysiology
, vol.17
, pp. 229-251
-
-
Ran, S.1
Volk, L.2
Hall, K.3
Flister, M.J.4
-
7
-
-
77957284078
-
Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin
-
Cueni LN, Hegyi I, Shin JW, Albinger-Hegyi A, Gruber S, Kunstfeld R, Moch H, and Detmar M (2010). Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. Am J Pathol 177, 1004-1016.
-
(2010)
Am J Pathol
, vol.177
, pp. 1004-1016
-
-
Cueni, L.N.1
Hegyi, I.2
Shin, J.W.3
Albinger-Hegyi, A.4
Gruber, S.5
Kunstfeld, R.6
Moch, H.7
Detmar, M.8
-
8
-
-
33750054757
-
Tumor and lymph node lymphangiogenesis- impact on cancer metastasis
-
Tobler NE and Detmar M (2006). Tumor and lymph node lymphangiogenesis- impact on cancer metastasis. J Leukoc Biol 80, 691-696.
-
(2006)
J Leukoc Biol
, vol.80
, pp. 691-696
-
-
Tobler, N.E.1
Detmar, M.2
-
9
-
-
33846857321
-
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites
-
Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, and Detmar M (2007). VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109, 1010-1017.
-
(2007)
Blood
, vol.109
, pp. 1010-1017
-
-
Hirakawa, S.1
Brown, L.F.2
Kodama, S.3
Paavonen, K.4
Alitalo, K.5
Detmar, M.6
-
10
-
-
84858307271
-
Tumor lymphangiogenesis as a potential therapeutic target
-
Duong T, Koopman P, and Francois M (2012). Tumor lymphangiogenesis as a potential therapeutic target. J Oncol 2012, 204946.
-
(2012)
J Oncol
, vol.2012
, pp. 204946
-
-
Duong, T.1
Koopman, P.2
Francois, M.3
-
11
-
-
81355164576
-
Breast cancer statistics, 2011
-
DeSantis C, Siegel R, Bandi P, and Jemal A (2011). Breast cancer statistics, 2011. CA Cancer J Clin 61, 409-418.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 409-418
-
-
Desantis, C.1
Siegel, R.2
Bandi, P.3
Jemal, A.4
-
12
-
-
43149120688
-
Development of new targeted therapies for breast cancer
-
Doyle DM and Miller KD (2008). Development of new targeted therapies for breast cancer. Breast Cancer 15, 49-56.
-
(2008)
Breast Cancer
, vol.15
, pp. 49-56
-
-
Doyle, D.M.1
Miller, K.D.2
-
13
-
-
80054864382
-
Reappraising antiangiogenic therapy for breast cancer
-
Kerbel RS (2011). Reappraising antiangiogenic therapy for breast cancer. Breast 20(suppl 3), S56-S60.
-
(2011)
Breast
, vol.20
, Issue.SUPPL. 3
-
-
Kerbel, R.S.1
-
14
-
-
79954987257
-
Understanding the value of antiangiogenic therapy in meta-static breast cancer
-
Martin M (2011). Understanding the value of antiangiogenic therapy in meta-static breast cancer. Curr Opin Oncol 23(suppl), S1.
-
(2011)
Curr Opin Oncol
, vol.23
, Issue.SUPPL.
-
-
Martin, M.1
-
15
-
-
84857179053
-
FDA cancels approval for bevacizumab in advanced breast cancer
-
Tanne JH (2011). FDA cancels approval for bevacizumab in advanced breast cancer. BMJ 343, d7684.
-
(2011)
BMJ
, vol.343
-
-
Tanne, J.H.1
-
16
-
-
60649106195
-
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
-
Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, Inoue M, Bergers G, Hanahan D, and Casanovas O (2009). Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220-231.
-
(2009)
Cancer Cell
, vol.15
, pp. 220-231
-
-
Paez-Ribes, M.1
Allen, E.2
Hudock, J.3
Takeda, T.4
Okuyama, H.5
Vinals, F.6
Inoue, M.7
Bergers, G.8
Hanahan, D.9
Casanovas, O.10
-
17
-
-
78650116154
-
Antiangiogenic therapy accelerates tumor metastasis
-
Ribatti D (2011). Antiangiogenic therapy accelerates tumor metastasis. Leuk Res 35, 24-26.
-
(2011)
Leuk Res
, vol.35
, pp. 24-26
-
-
Ribatti, D.1
-
18
-
-
52949084316
-
A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells
-
Karagiannis ED and Popel AS (2008). A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells. Proc Natl Acad Sci USA 105, 13775-13780.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 13775-13780
-
-
Karagiannis, E.D.1
Popel, A.S.2
-
19
-
-
80255123840
-
Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation
-
Lee E, Rosca EV, Pandey NB, and Popel AS (2011). Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation. Int J Biochem Cell Biol 43, 1812-1821.
-
(2011)
Int J Biochem Cell Biol
, vol.43
, pp. 1812-1821
-
-
Lee, E.1
Rosca, E.V.2
Pandey, N.B.3
Popel, A.S.4
-
20
-
-
0024354304
-
Determination of subcutaneous tumor size in athymic (nude) mice
-
Tomayko MM and Reynolds CP (1989). Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24, 148-154.
-
(1989)
Cancer Chemother Pharmacol
, vol.24
, pp. 148-154
-
-
Tomayko, M.M.1
Reynolds, C.P.2
-
21
-
-
70349330902
-
Lymphangiogenesis and cancer metastasis
-
Mumprecht V and Detmar M (2009). Lymphangiogenesis and cancer metastasis. J Cell Mol Med 13, 1405-1416.
-
(2009)
J Cell Mol Med
, vol.13
, pp. 1405-1416
-
-
Mumprecht, V.1
Detmar, M.2
-
22
-
-
17144402207
-
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
-
Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, and Detmar M (2005). VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201, 1089-1099.
-
(2005)
J Exp Med
, vol.201
, pp. 1089-1099
-
-
Hirakawa, S.1
Kodama, S.2
Kunstfeld, R.3
Kajiya, K.4
Brown, L.F.5
Detmar, M.6
-
23
-
-
41249088330
-
Blocking neuropilin-2 function inhibits tumor cell metastasis
-
Caunt M, Mak J, Liang WC, Stawicki S, Pan Q, Tong RK, Kowalski J, Ho C, Reslan HB, Ross J, et al. (2008). Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13, 331-342.
-
(2008)
Cancer Cell
, vol.13
, pp. 331-342
-
-
Caunt, M.1
Mak, J.2
Liang, W.C.3
Stawicki, S.4
Pan, Q.5
Tong, R.K.6
Kowalski, J.7
Ho, C.8
Reslan, H.B.9
Ross, J.10
-
24
-
-
55749110742
-
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization
-
Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, Cebe-Suarez S, Shimizu A, Edholm D, Ballmer-Hofer K, Kjellen L, et al. (2008). Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 112, 3638-3649.
-
(2008)
Blood
, vol.112
, pp. 3638-3649
-
-
Kawamura, H.1
Li, X.2
Goishi, K.3
van Meeteren, L.A.4
Jakobsson, L.5
Cebe-Suarez, S.6
Shimizu, A.7
Edholm, D.8
Ballmer-Hofer, K.9
Kjellen, L.10
-
25
-
-
73949097022
-
A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis
-
Tremmel M, Matzke A, Albrecht I, Laib AM, Olaku V, Ballmer-Hofer K, Christofori G, Heroult M, Augustin HG, Ponta H, et al. (2009). A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood 114, 5236-5244.
-
(2009)
Blood
, vol.114
, pp. 5236-5244
-
-
Tremmel, M.1
Matzke, A.2
Albrecht, I.3
Laib, A.M.4
Olaku, V.5
Ballmer-Hofer, K.6
Christofori, G.7
Heroult, M.8
Augustin, H.G.9
Ponta, H.10
-
26
-
-
4143136353
-
Expression of CD44v3 protein in human endothelial cells in vitro and in tumoral microvessels in vivo
-
Forster-Horvath C, Meszaros L, Raso E, Dome B, Ladanyi A, Morini M, Albini A, and Timar J (2004). Expression of CD44v3 protein in human endothelial cells in vitro and in tumoral microvessels in vivo. Microvasc Res 68, 110-118.
-
(2004)
Microvasc Res
, vol.68
, pp. 110-118
-
-
Forster-Horvath, C.1
Meszaros, L.2
Raso, E.3
Dome, B.4
Ladanyi, A.5
Morini, M.6
Albini, A.7
Timar, J.8
-
27
-
-
79959278619
-
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3
-
Kodera Y, Katanasaka Y, Kitamura Y, Tsuda H, Nishio K, Tamura T, and Koizumi F (2011). Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3. Breast Cancer Res 13, R66.
-
(2011)
Breast Cancer Res
, vol.13
-
-
Kodera, Y.1
Katanasaka, Y.2
Kitamura, Y.3
Tsuda, H.4
Nishio, K.5
Tamura, T.6
Koizumi, F.7
-
28
-
-
38049018155
-
A quantitative analysis of kinase inhibitor selectivity
-
Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI, Edeen PT, et al. (2008). A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26, 127-132.
-
(2008)
Nat Biotechnol
, vol.26
, pp. 127-132
-
-
Karaman, M.W.1
Herrgard, S.2
Treiber, D.K.3
Gallant, P.4
Atteridge, C.E.5
Campbell, B.T.6
Chan, K.W.7
Ciceri, P.8
Davis, M.I.9
Edeen, P.T.10
-
29
-
-
84864458283
-
Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model
-
Xin X, Majumder M, Girish GV, Mohindra V, Maruyama T, and Lala PK (2012). Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Lab Invest 92, 1115-1128.
-
(2012)
Lab Invest
, vol.92
, pp. 1115-1128
-
-
Xin, X.1
Majumder, M.2
Girish, G.V.3
Mohindra, V.4
Maruyama, T.5
Lala, P.K.6
-
30
-
-
56049097901
-
Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model
-
Shibata MA, Morimoto J, Shibata E, and Otsuki Y (2008). Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Ther 15, 776-786.
-
(2008)
Cancer Gene Ther
, vol.15
, pp. 776-786
-
-
Shibata, M.A.1
Morimoto, J.2
Shibata, E.3
Otsuki, Y.4
-
31
-
-
79959990517
-
Insulin-like growth factor-I receptor block-ade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45
-
Li H, Adachi Y, Yamamoto H, Min Y, Ohashi H, Ii M, Arimura Y, Endo T, Lee CT, Carbone DP, et al. (2011). Insulin-like growth factor-I receptor block-ade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45. Cancer 117, 3135-3147.
-
(2011)
Cancer
, vol.117
, pp. 3135-3147
-
-
Li, H.1
Adachi, Y.2
Yamamoto, H.3
Min, Y.4
Ohashi, H.5
Ii, M.6
Arimura, Y.7
Endo, T.8
Lee, C.T.9
Carbone, D.P.10
-
32
-
-
79960006764
-
Anti-angiogenic peptides for cancer therapeutics
-
Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, and Popel AS (2011). Anti-angiogenic peptides for cancer therapeutics. Curr Pharm Biotechnol 12, 1101-1116.
-
(2011)
Curr Pharm Biotechnol
, vol.12
, pp. 1101-1116
-
-
Rosca, E.V.1
Koskimaki, J.E.2
Rivera, C.G.3
Pandey, N.B.4
Tamiz, A.P.5
Popel, A.S.6
-
33
-
-
82255161187
-
Cross-talk between tumor cells and the microenvironment at the metastatic niche
-
Carlini MJ, De Lorenzo MS, and Puricelli L (2011). Cross-talk between tumor cells and the microenvironment at the metastatic niche. Curr Pharm Biotechnol 12, 1900-1908.
-
(2011)
Curr Pharm Biotechnol
, vol.12
, pp. 1900-1908
-
-
Carlini, M.J.1
de Lorenzo, M.S.2
Puricelli, L.3
-
34
-
-
84871611863
-
Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors
-
Koskimaki JE, Lee E, Chen W, Rivera CG, Rosca EV, Pandey NB, and Popel AS (2012). Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors. Angiogenesis 16, 159-170.
-
(2012)
Angiogenesis
, vol.16
, pp. 159-170
-
-
Koskimaki, J.E.1
Lee, E.2
Chen, W.3
Rivera, C.G.4
Rosca, E.V.5
Pandey, N.B.6
Popel, A.S.7
-
36
-
-
79955798791
-
Ramucirumab (IMC-1121B): Monoclonal antibody inhibition of vascular endothelial growth factor receptor-2
-
Spratlin J (2011). Ramucirumab (IMC-1121B): monoclonal antibody inhibition of vascular endothelial growth factor receptor-2. Curr Oncol Rep 13, 97-102.
-
(2011)
Curr Oncol Rep
, vol.13
, pp. 97-102
-
-
Spratlin, J.1
-
37
-
-
4143128938
-
Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells
-
Nguyen A, Chen P, and Cai H (2004). Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Lett 572, 307-313.
-
(2004)
FEBS Lett
, vol.572
, pp. 307-313
-
-
Nguyen, A.1
Chen, P.2
Cai, H.3
-
38
-
-
33749457974
-
Estrogen receptor positive breast cancer metastasis: Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes
-
Harrell JC, Dye WW, Allred DC, Jedlicka P, Spoelstra NS, Sartorius CA, and Horwitz KB (2006). Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. Cancer Res 66, 9308-9315.
-
(2006)
Cancer Res
, vol.66
, pp. 9308-9315
-
-
Harrell, J.C.1
Dye, W.W.2
Allred, D.C.3
Jedlicka, P.4
Spoelstra, N.S.5
Sartorius, C.A.6
Horwitz, K.B.7
|